About Ionis
Ionis is a Healthcare company based in Carlsbad (United States) founded in 1989. Ionis Pharmaceuticals is focused on RNA- and DNA-targeted medicines. It operates on a HealthTech and Licensing Model model. Ionis offers products and services including TRYNGOLZA (olezarsen) and Zilganersen. Its focus areas include Biotechnology and RNA/DNA Therapeutics.
Company details
Ionis Pharmaceuticals is engaged in discovering and delivering RNA- and DNA-targeted medicines for serious diseases. The company operates in the healthcare sector, targeting neurologic conditions, cardiometabolic disorders, and high-need patient areas. Innovative solutions are developed through advanced genetic science and industry-leading chemistry. Their pipeline addresses a broad spectrum of diseases, aiming to transform patient outcomes. Commitment to corporate responsibility ensures sustainable impact for stakeholders and communities.
Products & Services of Ionis
Ionis offers a comprehensive portfolio of products and services, including TRYNGOLZA (olezarsen) and Zilganersen.
Approved for treating familial chylomicronemia syndrome in adults.
Developed for Alexander disease with promising clinical results.
People of Ionis
319 people are tracked at Ionis (227 in leadership, 10 in board & advisors, 82 in team).
| Name | Role | Group |
|---|---|---|
Sanjay Bhanot | Vice President Metabolics & Translational Medicine | Leadership |
C. Frank Bennett | EVP, Chief Scientific Officer | Leadership |
Kevin Cornetto | Director, Drug Safety Surveillance | Leadership |
Brett P. Monia | Chief Executive Officer | Leadership |
Samuel Abariga | Medical Director, Drug Safety & Pharmacovigilance | Leadership |
Isaac Ballesteros | Assistant Director, Accounting | Leadership |
Ewa Karwatowska-Prokopczuk | VP, Cardiovascular Medicine | Leadership |
Patrick R. O’Neil | Chief Legal Officer and General Counsel | Leadership |
Alex Behling | Assistant Director- Biomarkers Bioanalysis | Leadership |
Adam Mullick | VP, Drug Discovery | Leadership |
Leo Sahelijo | VP, Translational Medicine | Leadership |
John Su | VP, Biometrics | Leadership |
Shannon Devers | Executive Vice President, Chief Human Resources Officer | Leadership |
Daniel Capaldi | VP, Analytical & Process Chemistry | Leadership |
Eric Swayze | Executive Vice President, Research At Ionis Pharmaceuticals, Inc. | Leadership |
Isaiah Cedillo | Executive Director, Manufacturing & Operations | Leadership |
Pratap Singh | Executive Director, Clinical Pharmacology | Leadership |
Holly Kordasiewicz | VP, Drug Discovery | Leadership |
Eugene Schneider | Executive Vice President, Chief Clinical Development Officer | Leadership |
Richard S. Geary | EVP, Chief Development Officer | Leadership |
299 more people are available in the full profile.
Complete people profiles for Ionis
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Ionis (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Ionis
Ionis was founded in 1989.
Ionis is headquartered in Carlsbad, United States. It is registered at Carlsbad, California, United States.
Ionis Pharmaceuticals is engaged in discovering and delivering RNA- and DNA-targeted medicines for serious diseases. The company operates in the healthcare sector, targeting neurologic conditions, cardiometabolic disorders, and high-need patient areas. Innovative solutions are developed through advanced genetic science and industry-leading chemistry. Their pipeline addresses a broad spectrum of diseases, aiming to transform patient outcomes. Commitment to corporate responsibility ensures sustainable impact for stakeholders and communities.
Ionis offers TRYNGOLZA (olezarsen) and Zilganersen.